Advertisement
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Transport of Prostaglandins

Hiroaki Kimura, Michio Takeda, Shinichi Narikawa, Atsushi Enomoto, Kimiyoshi Ichida and Hitoshi Endou
Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 293-298; DOI: https://doi.org/10.1124/jpet.301.1.293

Abstract

Prostaglandin E2 (PGE2) and prostaglandin F2α (PGF2α) have been used for the induction of labor and the termination of pregnancy. Renal excretion is shown to be an important pathway for the elimination of PGE2 and PGF2α. The purpose of this study was to elucidate the molecular mechanism of renal PGE2 and PGF2α transport using cells stably expressing human organic anion transporter (hOAT) 1, hOAT2, hOAT3, and hOAT4, and human organic cation transporter (hOCT) 1 and hOCT2. A time- and dose-dependent increase in PGE2 and PGF2αuptake was observed in cells expressing hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2. The Km values of PGE2 uptake by hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2 were 970, 713, 345, 154, 657, and 28.9 nM, respectively, whereas those of PGF2α uptake by hOAT1, hOAT3, hOAT4, hOCT1, and hOCT2 were 575, 1092, 692, 477, and 334 nM, respectively. PGE2and PGF2α significantly inhibited organic anion uptake by hOATs and organic cation uptake by hOCTs. In conclusion, considering the localization of these transporters, the results suggest that PGE2 and PGF2α transport in the basolateral membrane of the proximal tubule is mediated by multiple pathways including hOAT1, hOAT2, hOAT3, and hOCT2, whereas that in the apical side is mediated by hOAT4.

Prostglandins (PGs) play various physiological and pathophysiological roles. Among them, PGE2 and PGF2α are the predominant cyclooxygenase metabolites of arachidonic acid in the kidney (Breyer and Badr, 1996). PGE2 and PGF2α play an important role in the tubular reabsorption of salt and water as well as in the control of renal vascular resistance and the maintenance of glomerular hemodynamics. PGE2 is known to be converted enzymatically to PGF2α (Leslie and Levine, 1973; Terragno et al., 1976), and this conversion is enhanced in pathophysiological settings including sodium depletion (Siragy and Carey, 1997). Therapeutically, since both PGE2 and PGF2α have potent oxytoxic actions, the synthetic preparations of these compounds have been used to terminate pregnancy and to facilitate labor (Foegh and Ramwell, 2001). In addition, PGE2 has also been used for the treatment of gastric and duodenal ulcers, especially those induced by nonsteroidal anti-inflammatory drugs (Altman DF, 2000). Pharmacokinetically, it has been reported that 63% of PGE2 and 55.7% of PGF2αadministered were excreted into the urine in rats (Nishibori and Matsuoka, 1971; Nishibori et al., 1973). In addition, studies with perfused kidney tubules indicated that active vectorial PG transport across the epithelium is a two-step process consisting of active, energy-dependent basolateral uptake followed by passive apical secretion (Irish, 1979). Since PGE2 and PGF2α possess anionic moieties (Fig.1, A and B), it is suggested that urinary excretion of PGE2 and PGF2α is mediated by the organic anion transport system. However, little is known about the molecular mechanism of the tubular secretion of PGE2 and PGF2α.

Figure 1
Figure 1

Chemical structures of PGE2 (A) and PGF2α(B).

The secretion of numerous organic anions and cations, including endogenous metabolites, drugs, and xenobiotics, is an important physiological function of the renal proximal tubule. The process of secreting organic anions and cations through the proximal tubule cells is achieved via unidirectional transcellular transport, involving the uptake of organic anions and cations into the cells from the blood across the basolateral membrane, followed by extrusion across the brush-border membrane into the proximal tubule fluid (Pritchard and Miller, 1993). Recently, cDNAs encoding organic anion transporter (OAT) family have been successively cloned including OAT1 (Sekine et al., 1997; Sweet et al., 1997; Hosoyamada et al., 1999; Lu et al., 1999), OAT2 (Simonson et al., 1994; Sekine et al., 1998), OAT3 (Kusuhara et al., 1999; Cha et al., 2001) and OAT4 (Cha et al., 2000). The organic cation transporters (OCTs) isolated so far are OCT1 (Grundemann et al., 1994; Zhang et al., 1998), OCT2 (Okuda et al., 1996; Busch et al., 1998). Among these clones, human OAT1 (hOAT1), hOAT2, hOAT3, and hOCT2 were shown to be localized to the basolateral side of the proximal tubule (Gorboulev et al., 1997; Hosoyamada et al., 1999; Cha et al., 2001; Pietig et al., 2001; unpublished observation), whereas hOAT4 was localized to the apical side of the proximal tubule (Babu et al., 2002).

The purpose of this study was to elucidate the molecular mechanism of renal PGE2 and PGF2α transport. For this purpose, we established the proximal tubule cells stably expressing hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2.

Experimental Procedures

Materials.

[3H]PGE2 (7159.5 GBq/mmol) and [3H]PGF2α(7943.2 GBq/mmol) were purchased from Amersham Biosciences UK, Ltd. (Buckinghamshire, UK). 14C-Labeledpara-aminohippuric acid (PAH) (1.8648 GBq/mmol), [3H]estrone sulfate (ES) (1961 GBq/mmol) and [14C]tetraethylammonium (TEA) (2.035 GBq/mmol) were purchased from PerkinElmer Life Sciences (Boston, MA). PGE2 and PGF2α were obtained from Sigma-Aldrich (St. Louis, MO). Other materials used included fetal bovine serum, trypsin, and geneticin from Invitrogen (Carlsbad, CA), recombinant epidermal growth factor from Wakunaga (Hiroshima, Japan), insulin from Shimizu (Shizuoka, Japan), RITC 80-7 culture medium from Iwaki Co. (Tokyo, Japan) and TfX-50 from Promega (Madison, WI).

Cell Culture and Establishment of the Second Portion of Proximal Tubule (S2) Cells Stably Expressing hOAT2, hOAT4, hOCT1, and hOCT2.

S2 cells were established by culturing the microdissected S2 segment derived from transgenic mice harboring the temperature-sensitive simian virus 40 large T-antigen gene (Hosoyamada et al., 1996). During this establishment period, the functions of OATs and OCTs may have been lost. However, among the various cell lines stably expressing rat OAT3 that we have established, i.e., S2 cells, the terminal proximal tubule (S3) cells, Chinese hamster ovary cells and LLC-PK1 cells, we found that S2 cells alone exhibited phorbol 12-myristate 13-acetate-induced down-regulation of organic anion uptake, which is recognized in the intact proximal tubule (Takeda et al., 2000b). Thus, we suggest that S2 cells possess the essential machinery for the regulation of the OAT system and are the most suitable host for analyzing the OAT system. The establishment and characterization of S2 hOAT1 and S2 hOAT3 were reported previously (Takeda et al., 2000a). The full-length cDNA of hOAT2 was isolated by screening human kidney cDNA library using rat OAT2 cDNA as a probe (Sekine et al., 1998). The full-length cDNA of hOCT1 was obtained by reverse-transcription and polymerase chain reaction of cDNA using primers spanning the coding region of the published sequence of hOCT1 (Gorboulev et al., 1997). The full-length cDNA of hOCT2 was isolated by screening human kidney cDNA library using rat OCT2 cDNA (Okuda et al., 1996) as a probe. The full-length cDNAs of hOAT2, hOAT4 (Cha et al., 2000), hOCT1, and hOCT2 were subcloned into pcDNA3.1 (Invitrogen), a mammalian expression vector. S2hOAT2, S2 hOAT4, S2 hOCT1, and S2 hOCT2 were obtained by transfecting S2 cells with pcDNA3.1-hOAT2, pcDNA3.1-hOAT4, pcDNA3.1-hOCT1, and pcDNA3.1-hOCT2 coupled with pSV2neo, a neomycin resistance gene using TfX-50 according to the manufacturer's instructions. S2 cells transfected with pcDNA3.1 lacking an insert and pSV2neo were designated as S2 pcDNA3.1 (mock), and used as control. These cells were grown in a humidified incubator at 33°C and under 5% CO2 using RITC 80-7 medium containing 5% fetal bovine serum, 10 mg/ml transferrin, 0.08 U/ml insulin, 10 ng/ml recombinant epidermal growth factor, and 400 mg/ml geneticin. The cells were subcultured in a medium containing 0.05% trypsin-EDTA solution (containing 137 mM NaCl, 5.4 mM KCl, 5.5 mM glucose, 4 mM NaHCO3, 0.5 mM EDTA, and 5 mM Hepes; pH 7.2) and used for 25 to 35 passages. Clonal cells were isolated using a cloning cylinder and screened by determining the optimal substrate for each transporter, i.e., [14C]PAH for hOAT1 (Hosoyamada et al., 1999), [3H]PGF2α for hOAT2 (unpublished observation), [3H]ES for hOAT3 and hOAT4 (Cha et al., 2000, 2001) and [3H]TEA for hOCT1 and OCT2 (Okuda et al., 1996; Zhang et al., 1998).

Uptake Experiments.

Uptake experiments were performed as previously described (Takeda et al., 1999, 2000a,b, 2002). The S2 cells were seeded in 24-well tissue culture plates at a cell density of 1 × 105cells/well. After the cells were cultured for 2 days, the cells were washed three times with Dulbecco's modified phosphate-buffered saline (D-PBS) solution (containing 137 mM NaCl, 3 mM KCl, 8 mM NaHPO4, 1 mM KH2PO4, 1 mM CaCl2, and 0.5 MgCl2; pH 7.4), and then preincubated in the same solution in a water bath at 37°C for 10 min. The cells were then incubated in a solution containing either [3H]PGE2 or [3H]PGF2α at various concentrations as indicated in each experiment at 37°C for 1 min. The uptake was stopped by the addition of ice-cold D-PBS, and the cells were washed three times with the same solution. The cells in each well were lysed with 0.5 ml of 0.1 N sodium hydroxide and 2.5 ml of aquasol-2, and radioactivity was determined using a β-scintillation counter (LSC-3100; Aloka, Tokyo, Japan).

Inhibition Study.

To evaluate the inhibitory effects of PGE2 and PGF2α on organic anion uptake in S2 hOAT1, S2 hOAT2, S2 hOAT3, and S2 hOAT4, and organic cation uptake in S2 hOCT1 and S2 hOCT2, the cells were incubated in a solution containing either 5 μM [14C]PAH for 2 min (for hOAT1), 50 nM [3H]PGF2α for 1 min (for hOAT2), 50 nM [3H]ES for 2 min (for hOAT3 and hOAT4), or 5 μM [3H]TEA for 5 min (for hOCT1 and hOCT2) in the absence or presence of PGE2 and PGF2α at 37°C as described above. PGE2 and PGF2α were dissolved in dimethyl sulfoxide and diluted with the incubation medium. The final concentration of dimethyl sulfoxide in the incubation medium was adjusted to less than 1%.

Statistical Analysis.

Data are expressed as means ± S.E. Statistical differences were determined using the Student's unpairedt test. Differences were considered significant atP < 0.05.

Results

PGE2 and PGF2α Uptake Mediated by hOATs and hOCTs.

We have already observed that S2hOAT2 exhibited a time- and dose-dependent uptake of PGF2α with aKm value of 425 nM (unpublished observation). We further elucidated the time-dependent uptake of PGE2 and PGF2α in S2 cells stably expressing hOATs and hOCTs. As shown in Fig. 2, S2hOAT1 (A), S2 hOAT2 (B), S2hOAT3 (C), S2 hOAT4 (D), S2hOCT1 (E), and S2 hOCT2 (F) exhibited higher PGE2 uptake than mock. Similarly, as shown in Fig. 3, S2 hOAT1 (A), S2 hOAT3 (B), S2 hOAT4 (C), S2 hOCT1 (D), and S2hOCT2 (E) exhibited significantly higher PGF2αuptake than mock. The kinetics of PGE2 and PGF2α uptake were examined to evaluate the pharmacological characteristics of hOATs and hOCTs on the uptake of PGE2 and PGF2α. Figure4 shows the Eadie-Hofstee plots of the concentration dependence of PGE2 uptake by S2 hOAT1 (A), S2 hOAT2 (B), S2 hOAT3 (C), S2 hOAT4 (D), S2 hOCT1 (E), and S2 hOCT2 (F) after subtraction of uptake by mock. The estimatedKm values of PGE2 uptake by hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2 are listed in Table 1. On the other hand, Fig. 5 shows the Eadie-Hofstee plots of concentration dependence of PGF2α uptake by S2 hOAT1 (A), S2 hOAT3 (B), S2 hOAT4 (C), S2 hOCT1 (D), and S2hOCT2 (E) after subtraction of uptake by mock. The estimatedKm values of PGF2α uptake by hOAT1, hOAT3, hOAT4, hOCT1, and hOCT2 are also listed in Table 1. These results suggest that PGE2 and PGF2α transport is mediated by hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2.

Figure 2
Figure 2

Time course of PGE2 uptake by hOATs and hOCTs. S2 hOAT1 (A), S2 hOAT2 (B), S2 hOAT3 (C), S2 hOAT4 (D), S2hOCT1 (E), S2 hOCT2 (F), and mock were incubated in solution containing 5 nM [3H]PGE2 at 37°C up to 4 min. Each value represents the mean ± S.E. of four determinations from one typical experiment.

Figure 3
Figure 3

Time course of PGF2α uptake by hOATs and hOCTs. S2 hOAT1 (A), S2 hOAT3 (B), S2 hOAT4 (C), S2 hOCT1 (D), S2hOCT2 (E), and mock were incubated in solution containing 5 nM [3H]PGF2α at 37°C up to 4 min. Each value represents the mean ± S.E. of four determinations from one typical experiment.

Figure 4
Figure 4

Kinetic analysis of PGE2 uptake by hOATs and hOCTs. S2 hOAT1 (A), S2 hOAT2 (B), S2 hOAT3 (C) S2 hOAT4 (D), S2 hOCT1 (E), S2 hOCT2 (F), and mock were incubated in solution containing various concentrations of [3H]PGE2 at 37°C for 1 min. The values for the uptake by mock were subtracted. Analysis of Eadie-Hofstee plots was performed. Each value represents mean ± S.E. of three determinations from one typical experiment.

View this table:
Table 1

PGE2 and PGF2α uptake by hOATs and hOCTs

Figure 5
Figure 5

Kinetic analysis of PGF2α uptake by hOATs and hOCTs. S2 hOAT1 (A), S2 hOAT3 (B), S2 hOAT4 (C), S2 hOCT1 (D), S2hOCT2 (E), and mock were incubated in solution containing various concentrations of [3H]PGF2α at 37°C for 1 min. The values for the uptake by mock were subtracted. Analysis of Eadie-Hofstee plots was performed. Each value represents mean ± S.E. of three determinations from one typical experiment.

Inhibitory Effects of PGE2 and PGF2α on Organic Anion and Organic Cation Uptake.

We examined the inhibitory effects of PGE2 and PGF2α on organic anion uptake mediated by hOAT1, hOAT2, hOAT3, and hOAT4, and organic cation uptake mediated by hOCT1 and hOCT2. Table 2 shows that PGE2 significantly inhibited organic anion uptake mediated by hOAT1, hOAT2, hOAT3, and hOAT4 (n = 4, *P < 0.001 versus control), and organic cation uptake mediated by hOCT1 and hOCT2 (n = 4, *P< 0.001 and **P < 0.01 versus control). Similarly, PGF2α exerted a significant inhibitory effect on hOAT1-, hOAT2-, hOAT3-, and hOAT4-mediated organic anion uptake (n = 4, *P < 0.001 versus control), and hOCT1- and hOCT2-mediated organic cation uptake (hOCT1:n = 4, *P < 0.001 versus control; hOCT2: n = 4, **P < 0.01 versus control).

View this table:
Table 2

Effects of PGE2 and PGF2α on organic anion uptake by hOATs and the organic cation uptake by hOCTs

Discussion

hOAT1 and hOAT3 were shown to mediate the transport of nonsteroidal anti-inflammatory drugs, antitumor drugs, histamine H2 receptor antagonist, PGs, diuretics, angiotensin-converting enzyme inhibitors, and β-lactam antibiotics (Hosoyamada et al., 1999; Cha et al., 2001). Some differences in characteristics exist between hOAT1 and hOAT3, such as substrate specificity and localization: hOAT1 at the basolateral side of the S2 segment of the proximal tubule (Hosoyamada et al., 1999) versus hOAT3 at the first, second, and third segments (S1, S2, and S3) of the proximal tubule (Cha et al., 2001). In addition, hOAT1, but not hOAT3, exhibits transport properties as an exchanger (Hosoyamada et al., 1999; Cha et al., 2001). HOAT2, also shown to be localized to the basolateral side of the proximal tubule, mediates the transport of organic anions including salicylate and PGF2α (unpublished observation). HOAT4 also mediates the apical transport of various anionic drugs; however, this transporter exhibits relatively narrow substrate recognition compared with hOAT1 and hOAT3 (Cha et al., 2000; Babu et al., 2002).

HOCT1 was shown to be mainly localized to the liver and to mediate polyspecific pH independent transport of organic cations, whereas organic cation transport by hOCT2 was pH independent, electrogenic, and polyspecific. (Gorboulev et al.,1997; Busch et al., 1998; Zhang et al., 1998).

At present, limited information is available concerning renal tubular excretion of PGE2 and PGF2α; PG transporter-mediated transport of PGE2 and the inhibitory effect of PGE2 on rat-OAT1-mediated organic anion transport were reported (Kanai et al., 1995; Sekine et al., 1997). In this regard, the current results revealed that multiple pathways exist concerning the transport of PGs in the basolateral side of the proximal tubule, i.e., hOAT1, hOAT2, hOAT3, and hOCT2, whereas we could not exclude the possibility that transporters other than those analyzed in this study are also involved in PGE2 and PGF2α transport.

In addition to basolateral transporters, the characterization of the interaction between PGE2 or PGF2α and apical OATs is also important. In this regard, we found that hOAT4, an apical transporter of renal tubules, mediates the uptake of PGE2 as well as and PGF2α. In addition, we already observed that hOAT4 mediates the efflux of ES (Babu et al., 2002). Thus, it is possible that hOAT4 mediates the bidirectional transport of PGs on the apical side of the proximal tubule. On the other hand, we could not find the functional characteristics of hOAT4 as an exchanger (Cha et al., 2000). Instead, when the amount of PG reabsorbed from the tubular lumen together with that taken up from the basolateral side reaches a certain threshold that activates the hOAT4-mediated efflux, PG reabsorption from the tubular lumen may contribute to the secretion of PG into the tubular lumen. At present, the role of other apical transporters mediating organic anion transport remains unknown, including OAT-K1 (Saito et al., 1996), OAT-K2 (Masuda et al., 1999), organic anion-transporting peptide 1 (Jacquemin et al., 1994), multiple drug resistance protein 2 (Leier et al., 2000), and human type I sodium-dependent inorganic phosphate transporter (Uchino et al., 2000), and further study should be performed to elucidate this.

As shown in Fig. 1, PGE2 and PGF2α possess anionic moieties. This is consistent with the current results that hOAT1, hOAT2, hOAT3, and hOAT4 mediate the transport of PGE2 and PGF2α. In contrast, since both PGE2 and PGF2α possess no cationic moiety, hOCT1- and hOCT2-mediated PGE2and PGF2α uptakes were unexpected. Various substrates were shown to be transported via the OAT as well as the OCT system, and are called bisubstrates (Ullrich et al., 1993a,b). In this regard, PGE2 and PGF2αcould also be regarded as bisubstrates. Recently, we also found that acyclovir and ganciclovir are transported by hOAT1 as well as hOCT1 (Takeda et al., 2002). In addition, hOATs including hOAT1, hOAT2, and hOAT3 and hOCT2 are colocalized in the basolateral side of the proximal tubule (Gorboulev et al., 1997; Hosoyamada et al., 1999; Cha et al., 2001; Pietig et al., 2001; unpublished observation), and it is possible to design a model in which PGE2 and PGF2α are transported via OAT and OCT at the same time. Further studies should be performed to identify the mechanism underlying the involvement of OCTs in the transport of PGE2 and PGF2α.

In conclusion, the current results suggest that hOATs as well hOCTs are responsible for the transport of PGE2 and PGF2α in the basolateral side as well as the apical side of the renal tubule. The current results provide important information for safer and more efficient clinical use of PGE2 and PGF2α. Particular attention must be taken when these PGE2 and PGF2α are concomitantly used with other drugs that share common transporters with these PGs for tubular excretion. Otherwise, concomitant administration of PGE2 or PGF2α with other drugs may induce the increase in plasma concentrations of these PGs or other drugs, resulting in adverse drug reactions.

Footnotes

  • This study was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (11671048, 11694310, and 13671128), the Science Research Promotion Fund of the Japan Private School Promotion Foundation, and Research on Health Sciences Focusing on Drug Innovation from Japan Health Sciences Foundation.

  • Abbreviations:
    PG
    prostaglandin
    OAT
    organic anion transporter
    OCT
    organic cation transporter
    hOAT
    human OAT
    hOCT
    human OCT
    PAH
    para-aminohippuric acid
    ES
    estrone sulfate
    D-PBS
    Dulbecco's modified phosphate-buffered saline
    TEA
    tetraethylammonium
    • Received October 10, 2001.
    • Accepted December 27, 2001.

References

  1. ↵
    1. Katzung G
    1. Altman DF
    (2000) Drugs used in gastrointestinal diseases. in Basic & Clinical Pharmacology, ed Katzung G (Lange Medical Books/McGraw-Hill Medical Publishing Division, New York), 8th ed, pp 1064–1076.
  2. ↵
    Babu E, Takeda M, Narikawa S, Kobayashi Y, Enomoto A, Tojo A, Cha SH, Sekine T, Sakthisekaran D, and Endou H (2002) Role of human organic anion transporter 4 in the transport of ochratoxin. Biochim Biophys Acta, in press..
  3. ↵
    1. Brenner BM
    1. Breyer MD,
    2. Badr KF
    (1996) Arachidonic acid metabolites and the kidney. in The Kidney, ed Brenner BM (Saunders, New York), 6th ed, pp 754–788.
  4. ↵
    1. Busch AE,
    2. Karbach U,
    3. Miska D,
    4. Gorboulev V,
    5. Akhoundova A,
    6. Volk C,
    7. Arndt P,
    8. Ulzheimer JC,
    9. Sonders MS,
    10. Baumann C,
    11. et al.
    (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 54:342–352.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Cha SH,
    2. Sekine T,
    3. Fukushima JI,
    4. Kanai Y,
    5. Kobayashi Y,
    6. Goya T,
    7. Endou H
    (2001) Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 59:1277–1286.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Cha SH,
    2. Sekine T,
    3. Kusuhara H,
    4. Yu E,
    5. Kim YJ,
    6. Kim DK,
    7. Sugiyama Y,
    8. Kanai Y,
    9. Endou H
    (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275:4507–4512.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Katzung BG
    1. Foegh ML,
    2. Ramwell PW
    (2001) The eicosanoids: prostaglandins, thromboxanes, leukotrienes, and related compounds. in Basic & Clinical Pharmacology, ed Katzung BG (McGraw-Hill Medical Publishing Division, New York), 8th ed, pp 311–325.
  8. ↵
    1. Grundemann D,
    2. Gorboulev V,
    3. Gambaryan S,
    4. Veyhl M,
    5. Koepsell H
    (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature (Lond) 372:549–552.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Gorboulev V,
    2. Ulzheimer JC,
    3. Akhoundova A,
    4. Ulzheimer-Teuber I,
    5. Karbach U,
    6. Quester S,
    7. Baumann C,
    8. Lang F,
    9. Busch AE,
    10. Koepsell H
    (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871–881.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Hosoyamada M,
    2. Obinata M,
    3. Suzuki M,
    4. Endou H
    (1996) Cisplatin-induced toxicity in immortalized renal cell lines established from transgenic mice harboring temperature sensitive SV40 large T-antigen gene. Arch Toxicol 70:284–292.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Hosoyamada M,
    2. Sekine T,
    3. Kanai Y,
    4. Endou H
    (1999) Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 276:F122–F128.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Irish JM
    (1979) Secretion of prostaglandin E2 by rabbit proximal tubules. Am J Physiol 237:F268–F273.
    OpenUrl
  13. ↵
    1. Jacquemin E,
    2. Hagenbuch B,
    3. Stieger B,
    4. Wolkoff AW,
    5. Meier PJ
    (1994) Expression cloning of a rat liver Na+-independent organic anion transporter. Proc Natl Acad Sci USA 91:133–137.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Kanai N,
    2. Lu R,
    3. Satriano JA,
    4. Bao Y,
    5. Wolkoff AW,
    6. Schuster VL
    (1995) Identification and characterization of a prostaglandin transporter. Science (Wash DC) 268:866–869.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Kusuhara H,
    2. Sekine T,
    3. Utsunomiya-Tate N,
    4. Tsuda M,
    5. Kojima R,
    6. Cha SH,
    7. Sugiyama Y,
    8. Kanai Y,
    9. Endou H
    (1999) Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274:13675–13680.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Leier I,
    2. Hummel-Eisenbeiss J,
    3. Cui Y,
    4. Keppler D
    (2000) ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int 57:1636–1642.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Leslie CA,
    2. Levine L
    (1973) Evidence for the presence of a prostaglandin E2-9-keto reductase in rat organs. Biochem Biophys Res Commun 52:717–724.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Lu R,
    2. Chan BS,
    3. Schuster VL
    (1999) Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol 276:F295–F303.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Masuda S,
    2. Ibaramoto K,
    3. Takeuchi A,
    4. Takeuchi A,
    5. Saito H,
    6. Hashimoto Y,
    7. Inui KI
    (1999) Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney. Mol Pharmacol 55:743–752.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Nishibori T,
    2. Matsuoka Y
    (1971) Studies on absorption, distribution, excretion and metabolism of 9β-3H-prostaglandin F2α (3H-PGF2α) in rats. Iyakuhin Kenkyu 2:397–402.
    OpenUrl
  21. ↵
    1. Nishibori T,
    2. Matsuoka Y,
    3. Matsumoto T
    (1973) Studies on absorption, distribution, excretion and metabolism of 11β-3H-prostaglandin E2 (3H-PG E2) in rats. Appl Pharmacol 8:797–805.
    OpenUrl
  22. ↵
    1. Okuda M,
    2. Saito H,
    3. Urakami Y,
    4. Taknao M,
    5. Inui R
    (1996) cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 224:500–507.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Pietig G,
    2. Mehrens T,
    3. Hirsch JR,
    4. Cetinkaya I,
    5. Piechota H,
    6. Schlatter E
    (2001) Properties and regulation of organic cation transport in freshly isolated human proximal tubules. J Biol Chem 276:33741–33746.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Pritchard JB,
    2. Miller DS
    (1993) Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73:765–796.
    OpenUrlFREE Full Text
  25. ↵
    1. Saito H,
    2. Masuda S,
    3. Inui KI
    (1996) Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J Biol Chem 271:20719–20725.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Sekine T,
    2. Cha SH,
    3. Tsuda M,
    4. Apiwattanakul N,
    5. Nakajima N,
    6. Kanai Y,
    7. Endou H
    (1998) Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 42:179–182.
    OpenUrlCrossRef
  27. ↵
    1. Sekine T,
    2. Watanabe N,
    3. Hosoyamada M,
    4. Kanai Y,
    5. Endou H
    (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272:18526–18529.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Simonson GD,
    2. Vincent AC,
    3. Roberg KJ,
    4. Huang Y,
    5. Iwanij Y
    (1994) Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci 107:1065–1072.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Siragy HM,
    2. Carey RM
    (1997) The subtype 2 angiotensin receptor regulates renal prostaglandin F2alpha formation in conscious rats. Am J Physiol 273:R1103–R1107.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Sweet DH,
    2. Wolff NA,
    3. Pritchard JB
    (1997) Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 272:30088–30095.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Takeda M,
    2. Hosoyamada M,
    3. Cha SH,
    4. Sekine T,
    5. Endou H
    (2000a) Hydrogen peroxide downregulates human organic anion transporters in the basolateral membrane side of the proximal tubule. Life Sci 68:679–687.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Takeda M,
    2. Khamdang S,
    3. Narikawa S,
    4. Kimura H,
    5. Kobayashi Y,
    6. Yamamoto T,
    7. Cha SH,
    8. Sekine T,
    9. Endou H
    (2002) Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300:918–924.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Takeda M,
    2. Sekine T,
    3. Endou H
    (2000b) Regulation by protein kinase C of organic anion transport driven by rat organic anion transporter 3 (rOAT3). Life Sci 67:1087–1093.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Takeda M,
    2. Tojo A,
    3. Sekine T,
    4. Hosoyamada M,
    5. Kanai Y,
    6. Endou H
    (1999) Role of organic anion transporter 1 (OAT1) in cephaloridine-induced nephrotoxicity. Kidney Int 56:2128–2136.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Terragno NA,
    2. Malik KU,
    3. Nasjletti A,
    4. Terragno DA,
    5. Mcgiff JC
    (1976) Renal prostaglandins. Adv Prostaglandin Thromboxane Res 2:561–571.
    OpenUrlPubMed
  36. ↵
    1. Uchino H,
    2. Tamai I,
    3. Yamashita K,
    4. Minemoto Y,
    5. Sai Y,
    6. Yabuuchi H,
    7. Miyamoto KI,
    8. Takeda E,
    9. Tsuji A
    (2000) p-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. Biochem Biophys Res Commun 270:254–259.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Ullrich KJ,
    2. Rumrich G,
    3. David C,
    4. Fritzsch G
    (1993a) Bisubstrates: substances that interact with renal contraluminal organic anion and organic cation transport systems. Pfluegers Arch 425:280–299.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Ullrich KJ,
    2. Rumrich G,
    3. David C,
    4. Fritzsch G
    (1993b) Bisubstrates: substances that interact with both, renal contraluminal organic anion and organic cation transport systems. Pfluegers Arch 425:300–312.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Zhang L,
    2. Schaner ME,
    3. Giacomini KM
    (1998) Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J Pharmacol Exp Ther 286:354–361.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Transport of Prostaglandins

Hiroaki Kimura, Michio Takeda, Shinichi Narikawa, Atsushi Enomoto, Kimiyoshi Ichida and Hitoshi Endou
Journal of Pharmacology and Experimental Therapeutics April 1, 2002, 301 (1) 293-298; DOI: https://doi.org/10.1124/jpet.301.1.293
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement